Results 101 to 110 of about 190,941 (249)
Abstract Objective We have established a comprehensive sample handling protocol designed for the multiscale assessment of epileptogenic tissue. This protocol aims to identify novel therapeutic targets and enhance the diagnosis and stratification of patients with drug‐resistant epilepsy, thereby optimizing their treatment with anti‐seizure medications ...
Jenni Kyyriäinen +24 more
wiley +1 more source
Protocol for the Preparation of Polyphenols‐Polysaccharide Nanoparticles
ABSTRACT Polyphenols, natural compounds abundantly distributed in plants, possess potent antioxidant and anti‐inflammatory activities and hold promising potential in cardiovascular protection and the management of metabolic disorders. Nevertheless, their intrinsic instability and low bioavailability severely constrain their practical and large‐scale ...
Chenxu Bao +6 more
wiley +1 more source
Characterization of cDNAs Encoding Small GTP-Binding Proteins from Maize [PDF]
K. K. Kang, Hiroshi Sano, T. Kameya
openalex +1 more source
The pervasiveness of microplastic pollution poses a growing health risk, yet its long‐term metabolic consequences remain poorly defined. Here, we exposed mice to polyethylene terephthalate nanoparticle (NP) and combined histopathology, biochemistry, metabolomics, and metagenomics to resolve their interactions.
Yi Zhang +11 more
wiley +1 more source
ABSTRACT Background Psoriasis is a chronic inflammatory skin condition affecting millions globally, traditionally assessed via the Psoriasis Area and Severity Index (PASI). Despite its widespread use, PASI suffers from subjectivity, limited sensitivity for small lesions, and high interobserver variability.
Taig Mac Carthy +7 more
wiley +1 more source
Activity of 1,3-β-D-Glucan Synthase Requires the GTP-binding Protein Rho1 [PDF]
Paul Mazur, Walter F. Baginsky
openalex +1 more source
LRRK2 as a Potential Disease‐Modifying Target in Sporadic Parkinson's Disease
Abstract A growing understanding of the role that leucine‐rich repeat kinase 2 (LRRK2) plays in Parkinson's disease (PD) supports continued focus on this enzyme as a therapeutic target for PD. Accumulating evidence suggests that there are phenotypic, neuropathologic, and biological similarities between sporadic PD (sPD) and familial forms in which ...
Anthony E. Lang +12 more
wiley +1 more source

